Grant of stock options and reporting of transactions in

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Grant of stock options and reporting of transactions in accordance with Section 28a of the Securities Trading Act

Allerød, 2014-08-21 07:52 CEST (GLOBE NEWSWIRE) -- In accordance with Matas A/S’ Overall Guidelines for Incentive Pay, Matas A/S has today granted a total of 72,789 stock options, comprising 47.516 stock options to the executive management and 25.273 stock options to key employees, to purchase shares in Matas A/S under the long-term incentive plan. The stock options are subject to fulfilment of two KPIs weighted 50% each: one based on EBITDA and one based on the total shareholder return for the group. Upon fulfilment of the KPIs vesting will take place in three equal tranches after each of the financial years 2014/15, 2015/16 and 2016/17, and the KPI targets are defined for each of these periods. Vested stock options will not become available for exercise until after the announcement of the annual report for the financial year 2016/17 and participants have a subsequent period of two years to exercise the stock options. Each vested stock option entitles the holder to purchase one share in Matas A/S at a price per share of DKK 7.16. To the extent 100% of the 72,789 granted stock options vest in the period 2014/15 to 2016/17, the theoretical market value hereof as per today is DKK 8,214,407, calculated according to the Black-Scholes model based on assumptions of an exercise price of DKK 7.16, an average technically calculated duration of 5 years, a technically calculated volatility of 18%, a technically calculated dividend yield of 3.6%, and a technically calculated interest rate of 0.5%.  

Pursuant to Section 28a of the Securities Trading Act, Matas A/S shall hereby disclose information on transactions with the shares and associated securities of Matas A/S made by management and their related parties. Matas A/S has received information on below transactions in connection with allocation of stock options:  

Name Terje List
Reason Chief Executive Officer
Issuer Matas A/S
ISIN code Stock options related to ISIN code DK0060497295
Transaction Granted stock options which are conditional upon fulfilment of the KPIs and which upon vesting will not become available for exercise until after the announcement of the annual report for the financial year 2016/17
Designation Options to buy shares in Matas A/S
Trade day 21 August 2013
Market N/A
Number 32.892 (assuming 100% vesting)
Teoretical market value (DKK) Technically calculated valuation based on the Black-Scholes model of DKK 3,711,938 (assuming 100% vesting)
Name Anders T. Skole-Sørensen
Reason Chief Financial Officer
Issuer Matas A/S
ISIN code Stock options related to ISIN code DK0060497295
Transaction Granted stock options which are conditional upon fulfilment of the KPIs and which upon vesting will not become available for exercise until after the announcement of the annual report for the financial year 2016/17
Designation Options to buy shares in Matas A/S
Trade day 21 August 2013
Market N/A
Number 14,624 (assuming 100% vesting)
Teoretical market value (DKK) Technically calculated valuation based on the Black-Scholes model of DKK 1,650,352 (assuming 100% vesting)

Matas A/S

Enquiries Jesper Breitenstein Head of Investor Relations Tel. +45 27 80 76 75

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 232

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 136

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 104

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 373

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 103

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 0

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 49

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 133

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 38

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 135

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading

Top 5 Most Recently Viewed Articles

Cassava Sciences Takes Strategic Steps Amid Clinical Developments

Updated Category News Views 241

Cassava Sciences Provides Key Business Update Cassava Sciences, Inc. (NASDAQ: SAVA), a biotechnology company dedicated to developing innovative treatments for central nervous system disorders, has shared an important business update that affects both its operations and strategic direction. Important Study Results and Future Plans Recent data from the Phase 3 RETHINK-ALZ...

Continue Reading
ColdVentures Welcomes Dr. Barrak Alahmad as Strategic Advisor

Updated Category News Views 164

ColdVentures Expands Leadership with Key Appointment ColdVentures, a pioneering medical device company focused on addressing heat-related illnesses, has taken a significant step forward by appointing Dr. Barrak Alahmad as a strategic advisor. Dr. Alahmad, known for his expertise in environmental health and climate change, brings a wealth of knowledge to the role,...

Continue Reading
Season Group Hits Top 15% with EcoVadis Silver Medal

Updated Category News Views 40

Season Group's Silver Medal Moment Well, it's not every day that a company gets a pat on the back for actually doing something good, but that's what you have here with Season Group snagging the EcoVadis Silver Medal. It’s like the Oscars for sustainability, and it puts them in the top 15% of companies assessed globally by these sustainability gurus. That’s a title...

Continue Reading
LSPedia Achieves Notable Recognition in Business Category

Updated Category News Views 144

LSPedia Celebrated for Excellence in Business LSPedia is thrilled to announce its recent inclusion in Inc.'s 2024 Best in Business list, specifically in the Software as a Service category. This prestigious recognition highlights organizations that are industry leaders and stand out for their impactful achievements. A Testament to Industry Leadership In recognizing...

Continue Reading
Bev Colan Appointed as President of Venn Workforce Optimization

Updated Category News Views 216

Venn Workforce Optimization Welcomes New Leadership In an exciting development for Venn Workforce Optimization, Bev Colan has been named the company president. This marks a significant step for the organization, which specializes in locum tenens optimization and workforce solutions technology. Bev Colan: A Proven Leader Bev Colan joins the Venn team with over 20 years of...

Continue Reading